다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of hepatology : the journal of the European Association for the Study of the Liver, v.27 no.2, 1997년, pp.331 - 336
Naoumov, N.V. (aInstitute of Liver Studies, King's College School of Medicine and Dentistry, ,, London, UK) , Chokshi, S. , Metivier, E. , Maertens, G. , Johnson, P.J. , Williams, R.
AI-Helper
Background/Aims: The role of hepatitis C virus replication and different genotypes in the progression of cirrhosis to hepatocellular carcinoma is examined on the basis of a prospective follow-up of 1438 patients with histologically proven cirrhosis.Methods: The presence of HCV RNA, anti-HCV and char...
J Hepatol Johnson 4 140 1987 10.1016/S0168-8278(87)80021-1 Cirrhosis and etiology of hepatocellular carcinoma
Cancer Beasley 61 1942 1988 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J Hepatitis B virus. The major etiology of hepatocellular carcinoma
Lancet Colombo ii 1006 1989 10.1016/S0140-6736(89)91016-7 Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
Lancet Bruix ii 1004 1989 10.1016/S0140-6736(89)91015-5 Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma
Proc Natl Acad Sci USA Saito 87 6547 1990 10.1073/pnas.87.17.6547 Hepatitis C virus infection is associated with the development of hepatocelluar carcinoma
Hepatology Liang 18 1326 1993 Viral pathogenesis of hepatocellular carcinoma in the United States
Hepatology Kiyosawa 12 671 1990 10.1002/hep.1840120409 Interrelationship of blood transfusion non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus
J Clin Gastroenterol DiBisceglie 19 222 1994 10.1097/00004836-199410000-00011 Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C virus infection
N Engl J Med Tong 332 1463 1995 10.1056/NEJM199506013322202 Clinical outcomes after transfusion-associated hepatitis C
Q J Med Melia 211 391 1984 Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis
Semin Liver Dis Kew 4 136 1984 10.1055/s-2008-1040653 Relationship between hepatocellular carcinoma and cirrhosis
Hepatology Okuda 15 948 1992 10.1002/hep.1840150532 Hepatocellular carcinoma: recent progress
Hepatology Simmonds 21 570 1995 10.1002/hep.1840210243 Variability of hepatitis C virus
Hepatology Yoshioka 16 293 1992 10.1002/hep.1840160203 Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus
Hepatology Dusheiko 19 13 1994 10.1002/hep.1840190104 Hepatitis C virus genotypes - an investigation of type specific differences in geographic origin and disease
Ann Intern Med Nousbaum 122 161 1995 10.7326/0003-4819-122-3-199502010-00001 Hepatitis C virus type 1b(II) infection in France and Italy
Lancet Zaman i 1357 1985 10.1016/S0140-6736(85)91785-4 Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients
J Hepatol Johnson 7 S44 1988 10.1016/S0168-8278(88)80149-1 Development of hepatoma in cirrhotic patients from low and intermediate incidence areas: final results of a 10 year prospective study
J Med Virol Lin 38 220 1992 10.1002/jmv.1890380312 Polymerase chain reaction assay for hepatitis C virus RNA using single tube for reverse transcription and serial rounds of amplification with nested primer pairs
J Gen Virol Stuyver 74 1093 1993 10.1099/0022-1317-74-6-1093 Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
J Hepatol Vassiliadis 16 S13 1992 Characteristics of hepatitis B virus (HBV) cirrhotic tissue predisposing to subsequent development of hepatocellular carcinoma
Gastroenterology Tarao 103 595 1992 10.1016/0016-5085(92)90852-P DEvelopment of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis
Ann Intern Med Simonetti 116 97 1992 10.7326/0003-4819-116-2-97 Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis
Hepatology Paterlini 17 20 1993 10.1002/hep.1840170106 Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancer from HBsAg-negative patients: a study of a low endemic area
Lancet De Mitri 345 413 1995 10.1016/S0140-6736(95)90400-X HCV-associated liver cancer without cirrhosis
Hepatology Shiratori 22 1027 1995 10.1002/hep.1840220403 Characteristic difference of hepatocellular carcinoma between hepatitis B and C viral infection in Japan
Hepatology Takano 21 650 1995 10.1002/hep.1840210308 Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients
Hepatology Silini 21 285 1995 Differential distribution of hepatiits C virus genotypes in patients with and without liver function abnormalities
J Hepatol Bruno 23 111 1995 HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma(HCC) in cirrhotic patients: a prospective study
Hepatology Reid 20 4 250A 1994 Hepatitis C virus genotypes and hepatocellular carcinoma
Proc Natl Acad Sci USA Bukh 90 1848 1993 10.1073/pnas.90.5.1848 Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma
Lancet Sugitani 339 1018 1992 10.1016/0140-6736(92)90538-E Sensitivity of serological assays to identify blood donors with hepatitis C viraemia
Lancet Nishiguchi 346 1051 1995 10.1016/S0140-6736(95)91739-X Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
J Hepatol Mazzella 24 141 1996 10.1016/S0168-8278(96)80022-5 Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.